Zoe R Maylin

Work

University of British Columbia

Canada

Axitan Ltd

|

Research Associate

United Kingdom of Great Britain and Northern Ireland

→

Education

University of Surrey

United Kingdom of Great Britain and Northern Ireland
→
PhD

Publications

PROX1 is an early driver of lineage plasticity in prostate cancer

Journal of Clinical Investigation

journal-article

Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer

Cells

journal-article

Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer

Cells

journal-article

A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer

Frontiers in Oncology

journal-article

A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer

Frontiers in Oncology

journal-article

A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer

Frontiers in Oncology

journal-article

Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023)

ChemMedChem

journal-article

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance

ChemMedChem

journal-article

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance

ChemMedChem

journal-article

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance

ChemMedChem

journal-article

Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease

Translational Oncology

journal-article

Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease

Translational Oncology

journal-article

Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease

Translational Oncology

journal-article